PINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 5.711
EU - Europa 2.942
AS - Asia 2.329
AF - Africa 36
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 9
Totale 11.052
Nazione #
US - Stati Uniti d'America 5.682
CN - Cina 854
UA - Ucraina 781
IT - Italia 635
SG - Singapore 575
DE - Germania 372
HK - Hong Kong 337
FI - Finlandia 304
PL - Polonia 224
GB - Regno Unito 215
IE - Irlanda 211
IN - India 201
TR - Turchia 185
ID - Indonesia 70
VN - Vietnam 53
FR - Francia 52
SE - Svezia 44
BE - Belgio 39
CA - Canada 21
EG - Egitto 16
JP - Giappone 15
MU - Mauritius 13
EU - Europa 12
AU - Australia 11
CZ - Repubblica Ceca 11
RU - Federazione Russa 10
NL - Olanda 9
MX - Messico 8
GR - Grecia 7
KR - Corea 7
MK - Macedonia 6
IL - Israele 5
RO - Romania 5
AT - Austria 4
DK - Danimarca 4
MY - Malesia 4
NO - Norvegia 4
BR - Brasile 3
CY - Cipro 3
IR - Iran 3
NA - Namibia 3
OM - Oman 3
SA - Arabia Saudita 3
AR - Argentina 2
CD - Congo 2
CL - Cile 2
FJ - Figi 2
IQ - Iraq 2
KG - Kirghizistan 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
CO - Colombia 1
ES - Italia 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
MA - Marocco 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
Totale 11.052
Città #
Fairfield 600
Jacksonville 584
Woodbridge 548
Ashburn 467
Chandler 449
Singapore 434
Houston 382
Princeton 364
Hong Kong 334
New York 291
Wilmington 262
Ann Arbor 234
Cambridge 231
Seattle 226
Warsaw 223
Brescia 194
Dublin 188
Helsinki 184
Nanjing 172
Istanbul 171
Nanchang 90
Beijing 75
Des Moines 73
San Diego 61
Jakarta 60
Verona 60
Shanghai 57
Dong Ket 53
Shenyang 53
Changsha 49
Hebei 49
Milan 47
Jinan 46
Lancaster 46
Los Angeles 42
Brussels 39
Jiaxing 37
Tianjin 36
London 33
Washington 32
Hangzhou 24
Kunming 22
San Francisco 22
Lappeenranta 20
Pune 19
Munich 18
Trento 17
Zhengzhou 17
Guangzhou 15
Menlo Park 15
Romola 15
Azzano 14
Haikou 14
Rome 13
Lanzhou 12
Taizhou 11
Al Mansurah 10
Dearborn 10
Rozzano 10
Chicago 9
New Bedfont 9
Ningbo 9
Norwalk 9
Toronto 9
Cazzago San Martino 8
Tokyo 8
Hounslow 7
Islington 7
Santa Clara 7
Changchun 6
Fuzhou 6
Gunzenhausen 6
Gurugram 6
Kilburn 6
Mainz 6
Skopje 6
Taiyuan 6
Borgomanero 5
Brno 5
Kocaeli 5
Mumbai 5
Offenburg 5
Olomouc 5
Tel Aviv 5
Alexandria 4
Atlanta 4
Baden 4
Bergamo 4
Chennai 4
Frankfurt am Main 4
Leawood 4
Melbourne 4
Monza 4
Philadelphia 4
Piangipane 4
Prescot 4
Tadcaster 4
Acton 3
Albino 3
Bari 3
Totale 8.100
Nome #
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype 183
Central airways remodeling in COPD patients 145
Il deficit di Alfa1-Anti-tripsina. 143
Methods for Measuring Lung Volumes: Is There a Better One? 119
Exercise tolerance in obstructive sleep apnea-hypopnea (OSAH), before and after CPAP treatment: Effects of autonomic dysfunction improvement 118
Acute dynamic hyperinflation and systemic inflammation in stable COPD patients. 117
Alpha1-antitrypsin deficiency-associated cervical artery dissection. Report of three cases. 116
Vitamin D and health status in elderly. 115
Airway remodeling in allergen-challenged Brown Norway rats: Distribution of proteoglycans 113
Tidal airway closure during bronchoconstriction in asthma: usefulness of lung volume measurements. 108
Long-term physical training leads to airway remodelling in animal model. 108
Cardiac Sympathetic Hyperactivity in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea 107
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 102
Evaluating the Emergency Department admission and hospitalization trend for COPD Exacerbation and time-dependent Particulate Matter exposure 102
Alpha1-antitrypsin deficiency: a twenty-five years' experience. 98
Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients 98
The role of alpha-1-antitrypsin (AAT) Z polymers in the lung of patients with alpha-1-antitrypsin deficiency (AATD). 97
Epatocirrosi e versamento pleurico recidivante (idotorace epatico). 97
Diagnostic flow chart for targeted detection of alpha-1-antitrypsin deficiency 95
Skin prick-test reactivity to aeroallergens and allergic symptoms in an urban population of central Italy: a longitudinal study. 94
Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis. 92
Diagnostic flow chart for targered detection of Alpha-1-antitrypsin deficiency. 92
Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. 91
Alpha1-antitrypsin deficiency. The Brescia (Italy) clinical study [Il deficit di alfa1-antitripsina: Lo studio clinico di Brescia] 91
Predictors of nocturnal oxyhemoglobin desaturation in COPD. 89
Mild to moderate chronic airways disease does not carry an excess risk of cognitive dysfunction 89
Alpha1-Antitrypsin Deficiency in Spontaneous Cerebral Arterial Dissection. 88
Dose-Response curve to salbutamol during acute and chronic treatment with formoterol in COPD. 88
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 86
Tidal airway closure in asthma and COPD 84
COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments 82
Airway obstruction or closure during bronchoconstricction in asthma: can we preconize it? 81
Daytime approach to Obstructive Sleep Apnea phenotyping 81
Effect of PEEP on induced constriction is enhanced in decorin-deficient mice 80
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI 79
Diagnostic flow chart for targeted detection of Alpha1-antitrypsin deficiency. 78
Angiotensin II - receprot (AT1) blockade reduces ventricul arrhythimias in uncomplicated essential hypertensive patients. 78
Alpha1-antitrypsin Deficiecy and nephropathy 77
Characteristics and treatment regimens across ERS SHARP severe asthma registries 77
Impact of Particulate Matter on Emergency Department admissions and hospitalizations for COPD Exacerbation 76
Do GOLD stages of COPD severity really correspond to differences in health status? 75
Alpha1-antitrypsin deficiency and arterial dissection: report of four cases 74
Dynamic pulmonary hyperinflation and low grade systemic inflammaton in stable COPD patients. 74
Alpha1-antitrypsin deficiency and abdominal aortic aneurysms: does this association really exist? 74
Phenotyping OSAH patients during wakefulness 74
L'anziano di fronte ai problemi chirurgici: " I fattori di rischio" respiratori. 73
Early effects of CPAP on elastic aortic properties. 72
Predictors of exercise-induced airways obstruction in patients with mild asthma 72
Alpha-1-antitrypsin deficiency - The Brescia Clinical Study. 69
Effect of training on airways inflammatory response and remodeling in a rat model. 69
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 69
Consequences of SARS-COV-2 Pneumonia on Lung function 69
Alpha1-antitrypsin deficiency and asthma 68
Deficit di Alfa1-antitripsina. 67
Effects of short-term exposure to Particulate Matter on Emergency Department admissions for Asthma Exacerbation 67
Assessment of expiratory flow limitation in subjects with severe alpha-1-antitrypsin deficiency. 66
Inhaled corticosteroids in COPD: Trying to make a long story short 66
RETROSPECTIVE ANALYSIS AND RESULTS OF THE ALPHA1-ANTITRYPSIN DEFICIENCY CENTER ACTIVITY IN BRESCIA 66
Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool 66
Role of respiratory mechanics in the pathogenesis of airway hyperresponsiveness in obese subject. 65
ELASTIC PROPERTIES OF THE ASCENDING AORTA IN PATIENTS WITH ALPHA1-ANTITRYPSIN DEFICIENCY (Z-HOMOZYGOTES) 65
Dyspnea during night-time and at early morning in patients with stable copd is associated with supine tidal expiratory flow limitation 65
Phenotyping-based treatment improves obstructive sleep apnea symptoms and severity: a pilot study 64
Il deficit di alfa-1-antitripsina: lo studio clinico di Brescia. 63
ASSESSMENT OF RESPIRATORY FUNCTION IN PATIENTS AFTER SARS-COV-2 LUNG DISEASE 63
Valutazione ecocardiografica in una popolazione di pazienti con deficit di alfa1-antitripsina (genotipo ZZ). 62
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy 62
COPD EXACERBATION AND AIRBORNE POLLUTANTS: CHARACTERIZING THE ROLE OF PARTICULATE MATTER AND FINE PARTICULATE MATTER SHORT-TERM EXPOSURE 61
Alpha1-antitrypsin deficiency in spontaneous cerebral arterial dissection 60
Effect of precedine inspiratory speed and end-inspiratory on forced expiratory manoeuvre in healthy subjects and chronic obstructive pulmonary disease patients. 60
Echocardiographic evaluation in subjects with (1)-Antitrypsin deficiency 60
Diagnosing pneumothorax through standardized bilateral ultrasound images comparison 60
Effects of Chronic and Acute Pulmonary Hyperinflation on Phrenic Nerve Conduction in Patients with COPD 59
Role Of Particulate Matter On Emergency Department Visits For Asthma Exacerbation 59
Frequency of tiotropium bromide use and clinical features of patients with severe asthma in a real-life setting: Data from the severe asthma network in Italy (sani) registry 59
A Six-Month Follow-Up Evaluation of Lung Function in Patients with Previous SARS-COV-2 Pneumonia 59
Intra-epithelial polymerization, accumulation and secretion of alpha-1-antitrypsin (AAT) Z polymers in the lung of patients with alpha-1-antitrypsin deficiency (AATD). 58
Treatment of essential hypertension with hydrochlorothiazide combined with ACE-I or K+channel-I. 58
Assessment of expiratory flow limitation in subjects with severe alpha-1-Antitrypsin deficiency. alpha-1-antitrypsin deficiency - the biochemical basis of pulmonary emphysema. 58
COPD: It is time to change! 57
Emergency department visits for Asthma Exacerbation after short-term exposure to Particulate Matter: trend assessment in a European industrial city. 57
Proprietà elastiche dell’aorta ascendente in una popolazione di pazienti con deficit di alfa1-antitripsina (genotipo ZZ). 56
Role of sighs and breathing pattern in the pathogenesis of airway hyperresponsiveness in healty obese subjects. 55
Assessment of Small Airway Dysfunction and Z-Alpha1-Antitrypsin Polymers in Exhaled Breath Condensate in Healthy PiZZ Subjects 55
Time-Dependent Relationship Between Particulate Matter Exposure and COPD Exacerbations 55
CHARACTERIZATION OF THE AIRWAY WALL COMPLIANCE AFTER TREATMENT WITH BRONCHODILATOR IN COPD PATIENTS 55
Respiratory mechanics in pathogenesis of AHR in obese subjects. 54
Vasodilators and diuretics control orthopnea also by reversing expiratory flow limitation in subjects with chronic heart failure. 54
Severe alpha-1-antitrypsin deficiency : a cross-sectional clinical study. 53
Long-term physical trainign leads to airway remodelling in animal model. 53
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? 53
Longitudinal Study of the Respiratory Function in Preterm Born Children: Comparison Between Subjects with and without Bronchopulmonary Dysplasia 53
Long-term physical training leads to airway remodelling in animal model. 52
Average 24-h ambulatory BP distribution in uncomplicated males and females hypertensive patients: un age-based observational study. 52
In patients with bronchiectasis. is a casistis overview. 52
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 52
Has cardio-pulmonary exercise testing a role in detecting early emphysema in alpha-1-antitrysin deficiency? 51
The role of exercise testing to assess the disability by silicosis in Italy. 51
SMALL AIRWAYS DISEASE AND Z-ALPHA1-ANTITRYPSIN POLYMERS: IS THERE A CORRELATION? 51
CHARACTERIZATION OF THE IMPACT OF PARTICULATE MATTER AND FINE PARTICULATE MATTER ON ASTHMA EXACERBATION 51
Totale 7.626
Categoria #
all - tutte 74.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.020 0 0 0 0 0 173 182 176 61 264 36 128
2020/20212.202 71 166 53 197 197 268 100 243 295 238 238 136
2021/20221.469 68 168 46 165 29 101 55 132 95 175 123 312
2022/20231.326 208 109 60 88 85 320 2 177 134 6 44 93
2023/20241.719 69 25 156 164 86 426 56 88 362 35 29 223
2024/20251.174 14 68 75 581 429 7 0 0 0 0 0 0
Totale 11.555